Skip to main content

Table 1 Distribution of the various phenotypic variables in cases and controls

From: Effect of apolipoprotein A1 genetic polymorphisms on lipid profiles and the risk of coronary artery disease

  CAD (n = 300) Controls (n = 300) P
Age (years) 56.7 ± 9.9 56.1 ± 9.7 0.45
Sex (Male/Female) 238/62 231/69 0.49
Smoking status (Ever/Never) 84/216 46/254 <0.001
Diabetes (Positive/Negative) 74/226 42/258 0.001
Hypertension (Positive/Negative) 163/137 144/156 0.12
Obesity (Positive/Negative) 87/213 51/249 0.001
Hyperlipidemia (Positive/Negative) 93/207 49/251 <0.001
TG (mg/dL) 192.1 ± 86.7 167.5 ± 77.4 <0.001
TC (mg/dL) 198.7 ± 58.4 185.3 ± 50.1 0.003
HDL-C (mg/dL) 33.7 ± 11.6 38.9 ± 12.9 <0.001
LDL-C (mg/dL) 126.6 ± 37.4 112.9 ± 33.8 <0.001
VLDL-C (mg/dL) 38.4 ± 21.5 33.5 ± 20.3 0.004
ApoA1 (mg/dL) 123.5 ± 22.3 131.9 ± 23.5 <0.001
ApoB (mg/dL) 91.4 ± 27.3 90.6 ± 26.7 0.72
  1. Abbreviations: CAD, coronary artery disease; TG, triglyceride; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; VLDL-C, very-low-density lipoprotein cholesterol; Apo, apolipoprotein